Gastrointestinal Special Issue | CURE

April 05, 2018

Genomic testing of gastrointestinal tumors can be essential to proper treatment.

April 05, 2018

With immunotherapy continuing to command headlines in the world of oncology, it’s no surprise that patients with a variety of cancers wonder whether the strategy might help them address and overcome their illnesses.

April 05, 2018

It's amazing what a new year can bring.

April 04, 2018

After 10 years without a new drug for liver cancer, two approvals and a promising pipeline are changing the landscape.

April 04, 2018

Every survivor of a gastrointestinal cancer has unique follow-up needs. A ‘road map’ for this process can help.

March 31, 2018

Progress in cholangiocarcinoma treatment was long stalled, but now scientists are identifying genetic drivers likely to respond to novel drugs.

March 30, 2018

Funded posthumously by a "Jeopardy!" winner, an immunotherapy research project is under way.

March 25, 2018

A leader of the Pancreatic Cancer Action Network, which aims to double survival rates by 2020, outlines treatment strategies that could lead to success.

March 23, 2018

“Disease control is key in our patients with locally advanced disease, as it may lead to opportunities for additional treatment interventions, including radiotherapy, or even, in some favorable cases, surgical resection,” said lead study author Pascal Hammel, M.D., Ph.D.

March 22, 2018

Treatment with the PD-1 inhibitor Keytruda (pembrolizuumab) elicited promising progression-free survival (PFS) and overall survival (OS) results in patients with advanced hepatocellular carcinoma (HCC) who received previous treatment with Nexavar (sorafenib), according to phase 2 findings.

March 21, 2018

“Patients with advanced hepatocellular carcinoma often have a poor prognosis and limited treatment options following prior systemic therapy,” lead investigator Ghassan K. Abou-Alfa, M.D.

March 18, 2018

Immunotherapy may play a growing role in treating gastrointestinal cancers categorized as MSI-high.

March 17, 2018

Laparoscopy proves safer than open surgery and costs less than robotic resection for colorectal cancer.